Effects of Plasmodium berghei infection on cytochromes P-450 2E1 and 3A2

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 2, 1999, Pages 169-176

  Uhl, Kathleen ^a,c   Grace, J M ^a   Kocisko, D A ^a   Jennings, B T ^a   Mitchell, A L ^a   Brewer, T G ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Cytochrome P 450; Isozymes; Liver microsomes; Malaria; Sprague Dawley rats; Western blotting

Indexed keywords

CHLORZOXAZONE; CYTOCHROME P450; DRUG METABOLIZING ENZYME; ISOENZYME; OXYGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DISPOSITION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME KINETICS; IMMUNOBLOTTING; LIVER MICROSOME; MALARIA; MALE; NONHUMAN; PLASMODIUM BERGHEI; PROTEIN EXPRESSION; RAT;

EID: 0032860129     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190365     Document Type: Article

References (41)

1. Oaks S.C., Mitchell V.S., Pearson G.W., Carpenter C.C.J. (eds) (1991) : Malaria: Obstacles and Opportunities, A report of the committee for the study on malaria prevention and control: Status Review and Alternative Strategies. Division of International Health, Institute of Medicine, National Academy Press.
2. Na-Bangchang K., Limpaibul L. (1994) : The pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria. Br. J. Clin. Pharmacol., 38: 278-281.
3. White N.J., Looareesuwan S., Warrell D.A., Warrell M.J., Bunnag D., Harinasuta T. (1982) : Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am.J. Med, 73: 564-571.
4. White N.J. (1985) : Clinical pharmacokinetics of antimalarial drugs. Clin. Pharmacokinet., 10: 187-215.
5. Alvares A.P., Ueng T.H., Scheibel L.W., Hollingdale M.R. (1984) : Impairment of hepatic cytochrome P-450 dependent monooxygenases by the malaria parasite Plasmodium berghei. Mol. Biochem. Parasitol., 13: 277-282.
6. Glazier A.P., Kokwaro G.O., Edwards G. (1993) : Possible isozyme-specific effects of experimental malaria with Plasmodium berghei on cytochrome P450 activity in rat liver microsomes. J. Pharm. Pharmacol., 46: 352-355.
7. Kokwaro G.O., Glazier A.P., Ward S.A., Breckenridge A.M., Edwards G. (1993) : Effect of malaria infection and endotoxin-induced fever on phenacetin O-deethylation by rat liver microsomes. Biochem. Pharmacol., 45: 1235-1241.
8. Mihaly G.W., Date N.M., Veenendaal J.R., Newman K.T., Smallwood R.A. (1987) : Decreased hepatic elimination of pyrimethamine during malaria infection. Studies in the isolated perfused rat liver. Biochem. Pharmacol., 36: 2827-2829.
9. Mansor S.M., Edwards G., Roberts P.J., Ward S.A. (1991) : The effect of malaria infection on paracetamol disposition in the rat. Biochem. Pharmacol., 41: 1707-1711.
10. Murdoch R.T., Ghabrial H., Smallwood R.A., Morgan D.J. (1992) : Effect of malaria on phenol conjugation pathways in perfused rat liver. Biochem. Pharmacol., 43: 1229-1234.
11. Black R.H., Ray A.P. (1977) : Experimental studies of the potentiation of proguanil and pyrimethamine by dapsone using Plasmodium berghei in white mice. Ann. Trop. Med. Parasitol., 71: 131-139.
12. Guengerich F.P. (1977) : Separation and purification of multiple forms of microsomal cytochrome P-450: activities of different forms of cytochrome P-450 towards several compounds of environmental interest. J. Biol. Chem., 252: 3970-3979.
13. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. (1951) : Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275.
14. Omura T., Sato R.J. (1964) : The carbon-monoxide-binding pigment of liver microsomes. J. Biol. Chem., 239: 2370-2378.
15. Phillips A.H., Langdon R.G. (1962) : Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J. Biol. Chem., 237: 2652-2660.
16. Peter R., Bocker R.G., Beaune P.H., Iwasaki M., Guengerich F.P., Yang C.S. (1990) : Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 IIE1. Chem. Res. Toxicol., 3: 566-573.
17. Sonderfan A.J., Arlotto M.P., Dutton D.R., McMillen S.K., Parkinson A. (1987) : Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys., 255: 27-41.
18. Rosen S., Royeroft D.W., Hans J.E., Barry K.G. (1967) : The liver in malaria. Arch. Pathol., 83: 271-277.
19. Kokwaro G.O., Ismail S., Glazier A.P., Ward S.A., Edwards G. (1993) : Effect of malaria infection and endotoxin-induced fever on the metabolism of antipyrine and metronidazole in the rat. Biochem. Pharmacol., 45: 1243-1249.
20. Kokwaro G.O., Szwandt I.S.F., Glazier A.P., Ward S.A., Edwards G. (1993): Metabolism of caffeine and theophylline in rats with malaria and endotoxin-induced fever. Xeniobiotica, 23: 1391-1397.
21. Adedayo A., Arns P.A., Richards W.O., Wilkinson G.R., Branch R.A. (1998): Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6. Clin. Pharmacol. Ther., 64: 8-17.
22. Nebert D.W., McKinnon R.A., Puga A. (1996)v: Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol., 15: 273-280.
23. White N.J. (1985) : Clinical pharmacokinetics of antimalarial drugs. Clin. Pharm., 10: 187-215.
24. Chang K.C., Lauer B.A., Bell T.D., Chai H. (1978) : Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet, 1: 1132-1133.
25. Renton K.W., Gray J.D., Hall R.I. (1980) : Decreased elimination of theophylline after influenza vaccination. Can. Med. Assoc. J., 123: 288-290.
26. Renton K.W. (1981) : Effects of infection and immune stimulation on theophylline metabolism. Semin. Perinatol., 5: 378-382.
27. Renton K.W., Mannering G.J. (1976) : Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents. Biochem. Biophys. Res. Commun., 73: 343-348.
28. Chen Y.L., Florentin I., Batt A.M., Ferrari L., Giroud J.P., Chauvelot-Moachon L. (1992): Effect of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Biochem. Pharmacol., 44: 137-149.
29. Shedlodsky S.I., Swim A.T., Robinson J.M., Gallicchio V.S., Cohen D.A., McClain C.J. (1987): Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice. Life Sci, 40: 2331-2336.
30. Cribb A.E., Renton K.W. (1993) : Dissociation of xanthine oxidase induction and cytochrome P450 depression during interferon induction in the rat. Biochem. Pharmacol., 46: 2114-2117.
31. Morgan E.T. (1997) : Regulation of cytochromes P450 during inflammation and infection. Drug Metab. Rev., 29: 1129-1188.
32. Chung H., Brown D.R. (1976) : The mechanism of the effect of acute stress on hexobarbital metabolism. Toxicol. Appl. Pharmacol., 37: 313-318.
33. Bissell D.M., Hammaker L.E. (1976) : Cytochrome P-450 heme and the regulation of delta-aminolevulinic acid synthetase in the liver. Arch. Biochem. Biophys., 176: 103-112.
34. Koizumi A., Hasegawa L., Rodgers K.E., Ellefson D., Walford R., Imamura T. (1986) : Influence of H-2 haplotypes on poly IC induction of xanthine oxidase and poly IC induced decreases in P-450 mediated enzyme activities. Biochem. Biophys. Res. Commun., 138: 246-253..T. (1996) : Endotoxemia in rats is associated with induction of
35. Wink D.A, Osawa Y., Darbyshire J.F., Jones C.R., Eshenaur S.C., Nims R.W. (1993) : Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys., 300: 115-123.
36. Ryan D.E., Thomas P.E., Reik L.M., Levin W. (1982) : Purification, characterization and regulation of five rat hepatic microsomal cytochrome P-450 isozymes. Xenobiotica, 12: 727-744.
37. Sewer M.B, Koop D.R., Morgan E the P4504A subfamily and suppression of several other forms of cytochrome P450. Drug Metab. Dispos., 24: 401-407.
38. Sakai H., Okamoto T., Kikkawa J. (1992) : Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid. J. Pharmacol. Exp.Ther., 263: 381-386.
39. Singh G., Renton K.W. (1984) : Inhibition of the synthesis of hepatic cytochrome P-450 by the interferon-inducing agent poly rI.rCi. Can. J. Physiol. Pharmacol., 69: 379-383.
40. Moochhala A.M., Renton K.W. (1989) : The effect of IFN-alpha-Con1 on hepatic cytochrome P-450 and protein synthesis and degradation in hepatic microsomes. Int. J. Immunopharmacol., 13: 903-912.
41. Cribb A.E., Delaporte E., Kim S.G., Novak R.F., Renton K.W. (1994) : Regulation of cytochrome P-4501A and cytochrome P-4502E induction in the rat during the production of interferon alpha/beta. J. Pharmacol. Exp. Ther., 268: 487-494.